Prof. Lingbo Li | Tianjin Dexiang Biotechnology Co., Ltd. | China
Prof. Li Lingbo is a leading researcher in hematology and clinical neurology, with significant contributions to blood transfusion, laboratory medicine, and neurological disorder research. Over the past five years, he has published five SCI-indexed journal articles with a cumulative impact factor of 12.09, and six journals in total, contributing to a strong citation record that includes pivotal works such as the discovery of novel mutations within human ABO and RhD antigen genes, documented in the International Gene Database (GeneBank). He has edited and published three monographs, including An Introduction to Blood Group, advancing knowledge in blood group biology and transfusion medicine. His research portfolio encompasses three completed or ongoing research projects and three consultancy or industry collaborations, alongside one patent under process. Prof. Li serves as a peer reviewer for multiple prestigious journals, including the Chinese Journal of Blood Transfusion, Chinese Journal of Preventive Medicine, and the World Journal of Psychiatry (SCI, IF 3.9/Q1). He holds memberships in Sigma Xi, the Baikouen Spirit Research Society, and the Jilin Provincial Health Management Blood Transfusion Committee. With an h-index reflecting his scholarly influence, Prof. Li continues to advance the diagnosis, treatment, and prevention of blood and neurological disorders while developing innovative therapies and interventions, establishing him as a prominent figure in translational and clinical research.
Featured Publication
Zhong, J., Gao, Y., Mo, C., Zhang, Y., Luo, Y., & Li, L. (2025). From Rh blood group antigen antibody testing to “transfusionomics.” European Journal of Haematology.